Meeting
2020 Gastrointestinal Cancers Symposium
Expression of antibody-drug conjugates (ADC) biomarkers in colorectal cancer.
Authors
Sheeno P. Thyparambil
OncoPlex Diagnostics, Culver City, MD
Sheeno P. Thyparambil , Wei-Li Liao , Eunkyung An , Yuan Tian , Robert Heaton , Karl G. Sylvester , Xuefeng B. Ling
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Anal and Colorectal Cancer
Track
Colorectal Cancer,Anal Cancer
Sub Track
Diagnostics
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 17)
Abstract #
17
Poster Bd #
A11
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Proteomic profiling of antibody-drug conjugate (ADC) biomarkers in pancreatic cancer.
First Author: Sheeno P. Thyparambil
Poster
2024 ASCO Annual Meeting
Characterization of diverse targetable ERBB2 alterations in 512,993 patients with solid tumors.
First Author: Dazhi Liu
Poster
2024 ASCO Annual Meeting
Therapeutic implications of acquired high tumor mutational burden (TMB-H) after targeted therapy (TT) in metastatic colorectal cancer (mCRC).
First Author: Celine Yeh
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Clinical characteristics and outcomes of patients with metastatic colitis-associated cancer treated with EGFR inhibitors.
First Author: Celine Yeh